Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Samsung
Manufacturing
For $323M, Samsung Bio purchases land to increase CDMO footprint
Samsung has acquired additional land in South Korea to construct a new duplicate facility. The parcel was purchased for $323 million.
Kevin Dunleavy
Jul 18, 2022 4:53pm
AstraZeneca, Takeda, Biogen, Samsung and more—Fierce Pharma Asia
Feb 4, 2022 6:26am
Samsung unit denies report about Biogen buyout talks
Dec 30, 2021 8:13am
Biogen shares jump on $42 billion Samsung buyout reports
Dec 29, 2021 3:08pm
Samsung, Moderna, Brii and more—Fierce Pharma Asia
Aug 27, 2021 9:20am
JSR's CDMO arm plots $150M Research Triangle biologics plant
Dec 3, 2020 8:35am
